Skip to main content
Clinical Trials/ChiCTR2500096641
ChiCTR2500096641Not yet recruitingNot Applicable

艾司氯胺酮持续静脉镇痛治疗带状疱疹后神经痛患者的临床研究

自选课题(自筹)1 site in 1 countryStarted: January 27, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Locations
1
Primary Endpoint
NRS 评分

Study Overview

Brief Summary

回顾性分析艾司氯胺酮持续静脉镇痛治疗带状疱疹后神经痛患者的临床疗效

Study Design

Study Type
干预性研究
Primary Purpose
非随机对照试验
Masking
无

Eligibility Criteria

Ages
18 to 80 (—)
Sex
All

Inclusion Criteria

  • •1.PHN 诊断依据《中国带状疱疹诊疗专家共识(2022)》;
  • •2.有带状疱疹病史,病情痊愈后持续神经痛超过 1 个月;
  • •4.视觉模拟评分≥4 分;
  • •5.带状疱疹位于颈部、胸部和腰部;

Exclusion Criteria

  • •3.装有心脏起搏器、脊髓刺激器;
  • •4.存在脊柱严重畸形、椎间盘突出等;

Arms & Interventions

艾司氯胺酮组

Intervention: 艾司氯胺酮组

对照组

Intervention: 对照组

Outcomes

Primary Outcomes

NRS 评分

Time Frame: 术前、术后 7d、14d、28d

Secondary Outcomes

  • 中枢敏化评分(术前、术后 28d)
  • 血浆 BDNF(术前、术后 28d)
  • 匹兹堡睡眠质量指数(Pittsburgh sleep quality index ,PSQI)(术前、术后 7d、14d、28d)

Investigators

Sponsor
自选课题(自筹)

Study Sites (1)

Loading locations...

Similar Trials